Periodontal disease is a chronic inflammatory condition that leads to the destruction of supporting tooth structures and ultimately to tooth loss. Traditional diagnosis relies on clinical measurements ...

According to MarketsandMarkets™, the Cancer Biomarkers Market is projected to grow from about USD 28.25 billion in 2026 to ...

Please provide your email address to receive an email when new articles are posted on . Labcorp and Quest Diagnostics have both announced the availability of blood-based biomarker testing for ...

The global tissue diagnostics market is projected to grow at a CAGR of 6.35% during 2026–2031, driven by increasing cancer prevalence, rising adoption of precision medicine, and growing demand for ...

Friends of Cancer Research (FOCR) has issued a white paper calling on the U.S. Food and Drug Administration (FDA) to exercise greater regulatory flexibility in the validation of rare biomarker ...

WESTPORT, CT / ACCESSWIRE / April 2, 2024 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct", or the "Company"), a precision medicine-based women's health company focused on the development of ...

Diagnostic biomarkers are used to detect or confirm the presence of a disease or condition. They can help identify individuals with a particular disease or at high risk of developing the disease.

Collaboration aims to accelerate biomarker discovery, strengthen translational research capabilities, and support scalable ...

Biomarkers hold the key to more targeted and timely patient care, yet current tools for analyzing and identifying them often fall short in specificity, sensitivity, or scalability. The complexity of ...

Biomarker diagnostic tests in precision medicine can stratify patient sub-populations into responders versus non-responders. Precision medicine’s promise is selecting the right drug for the ...